EyePoint, Inc. Share Price
NASDAQ: EYPT | Micro CapEyePoint, Inc. Stock Performance
Open $4.63 | Prev. Close $4.63 | Circuit Range N/A |
Day Range $4.36 - $4.66 | Year Range $3.98 - $18.92 | Volume 1,61,751 |
Average Traded $4.49 |
EyePoint, Inc. Share Price Today
As of 29 August 2026, EyePoint, Inc.'s share price is $4.48. The stock opened at $4.63, compared to its previous close of $4.63. During today's trading session, EyePoint, Inc.'s share price traded between $4.36 and $4.66, with an average price of $4.51. Over the past 52 weeks, the stock has recorded a high of $18.92 and a low of $3.98. In terms of performance, EyePoint, Inc.'s share price has declined by 74.48% over the last six months and is down 61.25% on a year-on-year basis.
EyePoint, Inc. Share Price Chart
EyePoint, Inc. Stock Fundamentals & Key Indicators
Market Cap $328164.48 | PE Ratio (TTM) -1.41 | Dividend Yield N/A |
EPS (TTM) $-3.17 | Revenue (TTM) $31.37M | Return On Equity (TTM) -75.78% |
Profit Margin -739.42% | Debt to Equity 0.12 | Quarterly Earnings Growth YoY -103.44% |
EyePoint, Inc. Quarterly Profit & Loss
All figures in USD
EyePoint, Inc. Annual Profit & Loss
All figures in USD
About EyePoint, Inc.
EyePoint Pharmaceuticals, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is DURAVYU, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 3 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E that is in pre-clinical development phase for potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.
EyePoint, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $12.36 | $4.62 | -62.26% |
Jul 2026 | $14.73 | $12.23 | -14.36% |
Jun 2026 | $13.24 | $14.28 | +5.23% |
May 2026 | $13.44 | $13.57 | +2.88% |
Apr 2026 | $13.11 | $13.19 | +2.29% |
Mar 2026 | $17.54 | $12.89 | -26.55% |
Feb 2026 | $13.54 | $17.55 | +29.84% |
Jan 2026 | $18.50 | $13.52 | -26.04% |
Dec 2025 | $14.53 | $18.28 | +23.26% |
Nov 2025 | $13.26 | $14.83 | +13.12% |
Oct 2025 | $14.39 | $13.11 | -7.94% |
Sep 2025 | $11.89 | $14.24 | +23.18% |
EYPT Share Price FAQs
What is EyePoint, Inc. share price today?
What is the 52 week high and 52 week low of EyePoint, Inc. stock?
What is EYPT's market capitalisation today?
What is EYPT's net income for the last quarter?
What is the 5 year returns of EYPT?
What is the high & low stock price of EYPT today?
Can I buy EYPT shares in India?